Trastuzumab deruxtecan related interstitial lung disease
Author:
Weerakkody Yuranga
Publisher
Radiopaedia.org
Reference5 articles.
1. Jang Y, Jeong J, Kim J, Ahn J, Jung K, Kim S. CT Findings From Interstitial Lung Diseases in Patients With Metastatic Breast Cancer Treated With Fam-Trastuzumab Deruxtecan: A Single Institutional Experience. J Breast Cancer. 2022;25(1):49-56.
2. Nishino M, Kusumoto M, Bankier A et al. Trastuzumab Deruxtecan‒Related Interstitial Lung Disease/Pneumonitis: Computed Tomography Imaging Patterns to Guide Diagnosis and Management. JCO Precis Oncol. 2023;7(7):e2300391.
3. Abuhelwa Z, Alloghbi A, Alqahtani A, Nagasaka M. Trastuzumab Deruxtecan-Induced Interstitial Lung Disease/Pneumonitis in ERBB2-Positive Advanced Solid Malignancies: A Systematic Review. Drugs. 2022;82(9):979-87.
4. Powell C, Modi S, Iwata H et al. Pooled Analysis of Drug-Related Interstitial Lung Disease And/Or Pneumonitis in Nine Trastuzumab Deruxtecan Monotherapy Studies. ESMO Open. 2022;7(4):100554.
5. Errisuriz K, Bazan D, Verduzco Jr. R, Guedez R. Trastuzumab-Induced Interstitial Pneumonitis. Cureus. 2023;15(7):e42116.